Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials

被引：0
|
作者：
Bewley, A. [1 ]
Thyssen, J. P. [2 ]
Chiu, W. S. [3 ]
Rojo, R. [4 ]
Biswas, P. [5 ]
Feeney, C. [3 ]
DiBonaventura, M. [5 ]
Misery, L. [6 ]
Stander, S. [7 ]
Cork, M. [8 ]
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Inc, New York, NY USA
[6] Univ Hosp Ctr Brest, Brest, France
[7] Muenster Univ Hosp, Munster, Germany
[8] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
B06
引用
收藏
页码：E72 / E73
页数：2
相关论文
共 50 条
  • [1] ABROCITINIB MONOTHERAPY PROVIDES RAPID AND SUSTAINED ITCH IMPROVEMENT AT VARIOUS THRESHOLDS OF RESPONSE IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF THREE RANDOMIZED TRIALS
    Kwatra, Shawn G.
    Guttman-Yassky, Emma
    Biswas, Pinaki
    Myers, Daniela E.
    Guler, Erman
    Gooderham, Melinda J.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 21 - 21
  • [2] Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: results from JADE MONO-2 and JADE COMPARE
    Gooderham, M. J.
    Chu, C. -Y.
    Rojo, R.
    Valdez, H.
    Biswas, P.
    Cameron, M. C.
    Feeney, C.
    Encinas, G. A.
    Peeples-Lamirande, K.
    Cappelleri, J. C.
    Myers, D. E.
    DiBonaventura, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E72 - E72
  • [3] Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies
    Staender, Sonja
    Bhatia, Neal
    Gooderham, Melinda J.
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Biswas, Pinaki
    DiBonaventura, Marco
    Romero, William
    Farooqui, Saleem A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB148 - AB148
  • [4] Abrocitinib reduces skin pain in adolescent and adult patients with moderate-to-severe atopic dermatitis
    Thyssen, Jacob P.
    Bewley, Anthony
    Staender, Sonja
    Castro, Carla
    Misery, Laurent
    Kim, Brian
    Biswas, Pinaki
    Chan, Gary
    Myers, Daniela E.
    Watkins, Melissa
    Alderfer, Justine
    Guler, Erman
    Silverberg, Jonathan I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E118 - E118
  • [5] Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Facheris, Paola
    Gomez-Arias, Pedro Jesus
    Del Duca, Ester
    Da Rosa, Joel Correa
    Weidinger, Stephan
    Bissonnette, Robert
    Armstrong, April W.
    Seneschal, Julien
    Eyerich, Kilian
    Estrada, Yeriel D.
    Bose, Swaroop N.
    Xu, Dan
    Chen, Allshine
    Tatulych, Svitlana
    Guler, Erman
    Chan, Gary
    Page, Karen M.
    Kerkmann, Urs
    ALLERGY, 2024, 79 (05) : 1258 - 1270
  • [6] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
  • [7] Depth and rapidity of response with abrocitinib and dupilumab in patients with moderate-to-severe atopic dermatitis in JADE COMPARE
    Lio, P.
    Boguniewicz, M.
    Alexis, A.
    Lebwohl, M.
    Reich, K.
    Pink, A.
    Kabashima, K.
    Bissonnette, R.
    Nowicki, R. J.
    Valdez, H.
    Zhang, F.
    DiBonaventura, M.
    Clibborn, C.
    Cameron, M. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E138 - E139
  • [8] Impact of self-reported comorbid food allergy on efficacy and safety of abrocitinib and dupilumab in patients with moderate-to-severe atopic dermatitis: A pooled analysis of JADE COMPARE and JADE DARE
    Geng, B.
    Nosbaum, A.
    Boguniewicz, M.
    Vestergaard, C.
    Lazariciu, I.
    Feeney, C.
    Rebollo, F. J.
    Koppensteiner, H.
    Hernandez-Martin, I.
    ALLERGY, 2023, 78 : 140 - 140
  • [9] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [10] Worsening of itch before flaring in patients with moderate-to-severe atopic dermatitis treated with abrocitinib: a post hoc analysis of the phase 3 JADE REGIMEN trial
    Silverberg, Jonathan, I
    Kim, Brian S.
    de Bruin-Weller, Marjolein
    Weidinger, Stephan
    Steinhoff, Martin
    Biswas, Pinaki
    Kerkmann, Urs
    Feeney, Claire
    Koppensteiner, Herwig
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II31 - II32
12345